Researchers find new insight into how the brain decides to act

Researchers at Weill Cornell Medicine have identified neurons that drive animal brains to initiate actions without prompting from food or prey – a big step toward solving a big unanswered questions in neuroscience.

Treatment with endothelial cells reverses emphysema in model

The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Black patients with liver disease may face obstacles to transplants

Black patients who have chronic liver failure, also known as end-stage liver disease, are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study.

COVID-19 vaccines show safety, immunity in infant model

The research, co-led by Weill Cornell Medicine, suggests that vaccines for young children are likely important, safe tools to curtail the pandemic.

Lewis, Michener honored for diversity contributions

Mark E. Lewis, director of the School of Operations Research and Information Engineering, and Jamila Michener, associate professor of government, are the recipients of this year’s Faculty Award for Excellence in Research, Teaching and Service through Diversity.

Identifying social determinants of health in Brooklyn

New research from NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health.

Exoplanets get a cosmic front-row seat to find backlit Earth

Astronomers have identified 2,034 nearby star-systems – within 326 light-years – that could find life on Earth by watching our pale blue dot cross our sun.

Cooperative Extension grant aims to vaccinate NYS’ vulnerable

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Weill Cornell launches $1.5B campaign to change medicine

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched a $1.5 billion campaign that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.